We continue on our journey of “healing”, which began in 1912, fully aware that human health is our primary responsibility. Guided by this understanding, we believe in the importance of doing our job with great care, attention and integrity, and always maintaining the highest standards accordingly. Because we believe that, as a company, the way we achieve success is as important as the accomplishment itself.

With this belief, we have recorded our code of ethics, which have always served as an essential guide for us, in order to carry our stakeholders’ trust in and respect for us into the future. We then announced our code of ethics to our employees on December 30, 2015, and to external stakeholders on February 10, 2016. We consider one of our most critical responsibilities is commitment to these guidelines across all the work processes. The Ethics Board established within our company is set to assist our stakeholders with respect to all future content.

We attach great importance to working with the principles of ethics and transparency in all our business processes. We produce and deliver all of our products with the highest technology and in line with all quality and safety conditions required by all legal regulations, particularly international standards and intellectual rights. We consider product safety one of our indispensable principles. In this scope, our company’s pharmacovigilance system and cGMP-approved production facilities audited by national and international health authorities and companies have successfully underwent all audits carried out in 2019-2020.

Adi İbrahim Staff Regulations lay down the following obligations for the employees:

• Obligation to work efficiently and meticulously
• Obligation to protect company’s interests
• Confidentiality obligation
• Obligation to obey the law

Code of Ethics

• Impartiality
• Integrity
• Reliability
• Transparency
• Social good and respect for the environment
• Information security

Click here to see our Business Ethics Principles.

Business Ethics Reporting Hotline

Internal and external stakeholders can report to the Ethics Hotline any issue they consider to be contradicting Abdi İbrahim’s Business Ethics Principles. Each report is addressed and assessed against the Business Ethics Principles, and then submitted to the Ethics Board.
Complaints can be made to the Ethics Board via e-mail, mail, or phone. Suppliers, physicians, pharmacists and patients can report to etikhat@abdiibrahim.com.tr or the phone numbers available on our website. Ethics Hotline receives an average 30 reports in a year.

Click here for your reports, questions and comments about our ethics principles.

Launched in 2006 within Abdi İbrahim, the Internal Audit Department’s activities are governed by the Audit Committee Regulations and Internal Audit Regulations that took effect upon the Board decision of March 2013. Our team focuses on adding value to the risk management, control and governance processes via risk-based auditing.

Internal and external controls, early warning mechanisms and audits are strategic instruments in our Company’s fight against corruption and bribery. We audit the activities of our employees, customers and their subcontractors on a regular basis. Our primary endeavour is to make sure all stakeholders adopt and internalize the principles and ethical values as required. Our corporate values in that respect encompass the following principles:

• Valuing people
• Reliability
• Entrepreneurship and innovation
• Focus on quality
• Customer-oriented
• Dedicated to success
• Respect for the environment

At Abdi İbrahim, we conduct procurement activities in three main areas: direct material, indirect material, and investment. We plan these procurements, which total approximately 30,000 orders per year, in parallel with our long-term and short-term corporate policies. Supplier selection and improvement of business processes are among the company’s top priorities in its procurement processes. We choose to work with companies with whom we can develop long-term and sustainable collaborations and pay utmost attention to the compliance of our suppliers to legal regulations and ethical rules in the area of occupational health and safety. We also carry out activities to increase the capacity of our suppliers in the area of sustainability.

We bolster supplier contracts with the guidance of the Turkish Labor Law no. 4857 in the control and procedural processes. We engage in improvement and development work with our suppliers in a bid to mutually enhance business processes and construct a sustainable procurement and supply chain.

Being the first accredited pharmaceutical R&D Centre in Turkey, we provide state-of-the-art services at our latest formulation and analytical method development labs. We have the capability and infrastructure to develop pharmaceuticals through inhalation technology and nanotechnology to meet the ever-changing and progressive needs of the national and international pharma industries.

With a team of 133, our R&D Centre focuses on developing innovative and added value products, achieving high success rate in bioequivalence studies, accelerating the processes for signature product development and preparing Common Technical Document (CTD) files for Turkey, Europe and other markets. We conduct joint projects with local and global scientific institutions and transfer know-how.

Intellectual and Industrial Property Rights

Leading the Turkish pharmaceutical market in R&D funds, our Company has, as of the end of 2020, filed 174 patent applications in Turkey, Europe and globally, with 41 approved patents in Turkey and Europe combined.